Mechanisms of respiratory failure produced by neostigmine and diisopropyl fluorophosphate

Neal Fleming, Theresa R. Henderson, Kenneth L. Dretchen

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Acetylcholinesterase inhibitors produce diverse physiologic effects, but lethal exposure consistently produces respiratory failure due to neuromascular paralysis or depression of respiratory control centers in the medulla. Simultaneous measurement of gastrocnemius muscle contraction and efferent phrenic nerve activity was used to determine the primary cause of respiratory failure produced by neosligmine and diisopropyi fluorophosphate (DFP) in anesthetized cats. Both neostigmine and DFP abolished phrenic nerve activity prior to producing neuromuscular blockade. Furthermore, neostigmine did not alter brain acetylcholinesterase activity and pretreatment with either atropine methylbromide or atropine increased the dose of neostigmine required to abolish phrenic nerve activity. In contrast, DFP abolished brain cholineslerase activity and only atropine inhibited its respiratory effects. Despite the loss of efferent phrenic nerve activity, there is no evidence of a direct effect of neostigmine on respiratory control centers. Neostigmine may instead alter afferent inputs which modulate respiration to produce a reflex respiratory failure.

Original languageEnglish (US)
Pages (from-to)85-91
Number of pages7
JournalEuropean Journal of Pharmacology
Volume195
Issue number1
DOIs
StatePublished - Mar 19 1991
Externally publishedYes

    Fingerprint

Keywords

  • Acetylcholinesterase inhibitors (organophosphate, carbamate)
  • Diisopropyl fluorophosphate (DFP)
  • Neostigmine
  • Respiratory failure

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this